Trial NCT04756505

View at ClinicalTrials.gov 
Org. Study IDs: 2020-0245
Secondary IDs: 2020-0245 NCI-2021-00434

Last trial update was posted on 2023-12-27

MeSH Interventions

Immunoglobulin G Interleukin-12

MeSH Conditions

Adenocarcinoma Breast Neoplasms

Other Conditions

Anatomic Stage IV Breast Cancer AJCC v8 Hormone Receptor Positive Breast Adenocarcinoma Metastatic Breast Carcinoma Metastatic HER2 Negative Breast Adenocarcinoma Prognostic Stage IV Breast Cancer AJCC v8

Stopping Reasons

Per Sponsor Request-no longer manufacturing the study drug

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID